FDA
FDA Articles
As the second week of the New Year is now underway, a few biotech companies made sizable runs to kick off the week.
Published:
Last Updated:
2017 could be different for the health care sector. It is very possible that this new administration could lead to more positive trials, FDA approvals, and mergers and acquisitions.
Published:
Last Updated:
Some biopharma companies can see a massive upside just from winning a single mid-stage trial or even achieving as much as a Fast Track designation from the FDA.
Published:
Last Updated:
As the markets are continuing to heat up, a few biopharma stocks made massive gains on Thursday. There is a very positive sentiment in the health care sector in anticipation of the new Trump...
Published:
Last Updated:
Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year.
Published:
Last Updated:
A few biotech and pharma companies were on the move Wednesday, some making absolutely massive gains on the day, giving more credence to the Trump rally and positive sentiment for the health care...
Published:
Last Updated:
FibroGen could be a very important stock in its sector in 2017, with its data from multiple studies coming out early in the year.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts for biotech and pharmaceutical companies that are coming up in the first two months of 2017.
Published:
Last Updated:
Shares of Cempra were halved on Thursday after the company received a Complete Response Letter from the U.S. Food and Drug Administration (FDA).
Published:
Last Updated:
Galena Biopharma, Inc. (NASDAQ: GALE) saw its shares jump on Wednesday after a key U.S. Food and Drug Administration (FDA) approval. The company announced that it has confirmed the regulatory pathway...
Published:
Last Updated:
Shares of Amphastar Pharmaceuticals fell on Tuesday after the company announced that a subsidiary had received a Complete Response Letter from the FDA.
Published:
Last Updated:
Seattle Genetics shares were down double-digits after the company announced that the FDA has placed holds on several early-stage clinical trials of its leukemia drug candidate.
Published:
Last Updated:
Clovis Oncology, Inc. (NASDAQ: CLVS) is watching its shares hit a new 52-week high after the company reported a key U.S. Food and Drug Administration (FDA) approval. Essentially, the FDA approved...
Published:
Last Updated:
Vericel shares jumped sharply early Wednesday after the company announced that the FDA has approved its treatment of symptomatic cartilage defects of the knee in adults.
Published:
Last Updated:
Achaogen, Inc. (NASDAQ: AKAO) saw its shares continue to rise late on Tuesday after the company reported that it would conduct a secondary offering. The company said that it would be offering up to...
Published:
Last Updated: